These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35755818)

  • 1. Current Advances in CETSA.
    Tolvanen TA
    Front Mol Biosci; 2022; 9():866764. PubMed ID: 35755818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products.
    Tu Y; Tan L; Tao H; Li Y; Liu H
    Phytomedicine; 2023 Jul; 116():154862. PubMed ID: 37216761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular thermal shift assay: an approach to identify and assess protein target engagement.
    Zhang L; Wang Y; Zheng C; Zhou Z; Chen Z
    Expert Rev Proteomics; 2024; 21(9-10):387-400. PubMed ID: 39317941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved drug target deconvolution with PISA-DIA using an extended, overlapping temperature gradient.
    Emery-Corbin SJ; Yousef JM; Adhikari S; Sumardy F; Nhu D; van Delft MF; Lessene G; Dziekan J; Webb AI; Dagley LF
    Proteomics; 2024 Aug; 24(16):e2300644. PubMed ID: 38766901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target Engagement of Small Molecules: Thermal Profiling Approaches on Different Levels.
    Reckzeh ES; Brockmeyer A; Metz M; Waldmann H; Janning P
    Methods Mol Biol; 2019; 1888():73-98. PubMed ID: 30519941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based Cellular Thermal Shift Assay (CETSA®) for target deconvolution in phenotypic drug discovery.
    Friman T
    Bioorg Med Chem; 2020 Jan; 28(1):115174. PubMed ID: 31767405
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Lenz T; Stühler K
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput Cellular Thermal Shift Assays in Research and Drug Discovery.
    Henderson MJ; Holbert MA; Simeonov A; Kallal LA
    SLAS Discov; 2020 Feb; 25(2):137-147. PubMed ID: 31566060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1.
    McNulty DE; Bonnette WG; Qi H; Wang L; Ho TF; Waszkiewicz A; Kallal LA; Nagarajan RP; Stern M; Quinn AM; Creasy CL; Su DS; Graves AP; Annan RS; Sweitzer SM; Holbert MA
    SLAS Discov; 2018 Jan; 23(1):34-46. PubMed ID: 28957646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies.
    Martinez Molina D; Nordlund P
    Annu Rev Pharmacol Toxicol; 2016; 56():141-61. PubMed ID: 26566155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Horizontal Cell Biology: Monitoring Global Changes of Protein Interaction States with the Proteome-Wide Cellular Thermal Shift Assay (CETSA).
    Dai L; Prabhu N; Yu LY; Bacanu S; Ramos AD; Nordlund P
    Annu Rev Biochem; 2019 Jun; 88():383-408. PubMed ID: 30939043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-Time Cellular Thermal Shift Assay to Monitor Target Engagement.
    Sanchez TW; Ronzetti MH; Owens AE; Antony M; Voss T; Wallgren E; Talley D; Balakrishnan K; Leyes Porello SE; Rai G; Marugan JJ; Michael SG; Baljinnyam B; Southall N; Simeonov A; Henderson MJ
    ACS Chem Biol; 2022 Sep; 17(9):2471-2482. PubMed ID: 36049119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1.
    Shaw J; Dale I; Hemsley P; Leach L; Dekki N; Orme JP; Talbot V; Narvaez AJ; Bista M; Martinez Molina D; Dabrowski M; Main MJ; Gianni D
    SLAS Discov; 2019 Feb; 24(2):121-132. PubMed ID: 30543471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome Profiling.
    George AL; Sidgwick FR; Watt JE; Martin MP; Trost M; Marín-Rubio JL; Dueñas ME
    J Proteome Res; 2023 Aug; 22(8):2629-2640. PubMed ID: 37439223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thermal proteome profiling: a technique for a comprehensive assessment of protein status].
    Qiu Y; Zhai B; Bai Y; Chen S; Zhang J
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3628-3637. PubMed ID: 36305398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target.
    Friman T; Chernobrovkin A; Martinez Molina D; Arnold L
    SLAS Discov; 2021 Mar; 26(3):336-344. PubMed ID: 33208020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal Proteome Profiling for Drug Target Identification and Probing of Protein States.
    Sauer P; Bantscheff M
    Methods Mol Biol; 2023; 2718():73-98. PubMed ID: 37665455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HiBiT Cellular Thermal Shift Assay (HiBiT CETSA).
    Ramachandran S; Szewczyk M; Barghout SH; Ciulli A; Barsyte-Lovejoy D; Vu V
    Methods Mol Biol; 2023; 2706():149-165. PubMed ID: 37558947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Label-free target protein characterization for small molecule drugs: recent advances in methods and applications.
    Feng F; Zhang W; Chai Y; Guo D; Chen X
    J Pharm Biomed Anal; 2023 Jan; 223():115107. PubMed ID: 36334421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CETSA in integrated proteomics studies of cellular processes.
    Prabhu N; Dai L; Nordlund P
    Curr Opin Chem Biol; 2020 Feb; 54():54-62. PubMed ID: 31838273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.